Medytox

Medytox Inc. is a South Korean global biopharmaceutical company established on May 2, 2000, headquartered in Seoul, South Korea. The company specializes in the research, development, and manufacture of botulinum toxin products and hyaluronic acid dermal fillers. Medytox launched its flagship botulinum toxin type A product, Meditoxin® (exported as Neuronox®, Siax®, Botulift®, Cunox®, Acebloc®), in 2006 and achieved nearly 40% market share in South Korea by 2009. The company's product portfolio includes multiple botulinum toxin formulations (Neuronox®, INNOTOX®, Coretox®, NEWLUX®) and hyaluronic acid fillers (Neuramis®, Atiere, Potenfill), as well as the NEURADERM skincare line. Medytox operates R&D centers in Gwanggyo and Osong, manufacturing plants in Ochang and Osong, and has international subsidiaries in the USA (Luvantas), Taiwan, Hong Kong, Thailand, and Japan.